A Novel Technology Platform for Bone Regeneration and Cancer Treatment

In this Q&A, Novadip’s co-founder and CEO Denis Dufrane, Ph.D., discusses the company’s autologous cell-based and off-the-shelf cell-free products that are advancing through and to the clinic.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: